186 related articles for article (PubMed ID: 32530328)
1. Is there still a role for SERMs in menopause management?
Lello S; Capozzi A; Scambia G
Gynecol Endocrinol; 2020 Jul; 36(7):567-568. PubMed ID: 32530328
[No Abstract] [Full Text] [Related]
2. [Specific estrogen receptor modulators (SERMs)].
Trémollières F; Lopes P
Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of selective estrogen receptor modulators.
Krueger PM
J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S6-8. PubMed ID: 11105457
[TBL] [Abstract][Full Text] [Related]
4. Available medical choices for the management of menopause.
Castelo-Branco C; Palacios S; Calaf J; Vázquez F; Lanchares JL
Maturitas; 2005 Nov; 52 Suppl 1():S61-70. PubMed ID: 16213114
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene: risks and benefits.
Barrett-Connor E
Ann N Y Acad Sci; 2001 Dec; 949():295-303. PubMed ID: 11795366
[TBL] [Abstract][Full Text] [Related]
6. [Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis].
Meczekalski B; Czyzyk A
Ginekol Pol; 2009 Mar; 80(3):213-7. PubMed ID: 19382614
[TBL] [Abstract][Full Text] [Related]
7. A new approach to menopausal therapy: the tissue selective estrogen complex.
Komm BS
Reprod Sci; 2008 Dec; 15(10):984-92. PubMed ID: 19088368
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
Pfeilschifter J
Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
[TBL] [Abstract][Full Text] [Related]
9. [Phytoestrogens and SERMS, alternatives to classical hormone therapy?].
Huber J
Ther Umsch; 2000 Oct; 57(10):651-4. PubMed ID: 11081378
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of specific estrogen receptor modulators (SERMs).
Ibrahim NK; Hortobagyi GN
Surg Oncol; 1999 Aug; 8(2):103-23. PubMed ID: 10732962
[TBL] [Abstract][Full Text] [Related]
11. [Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].
Valéra MC; Chantalat E; Vinel A; Benoit T; Guillaume M; Game X; Gourdy P; Trémollières F; Payrastre B; Arnal JF
Presse Med; 2015; 44(7-8):805-11. PubMed ID: 26278157
[TBL] [Abstract][Full Text] [Related]
12. Developments in the management of menopause and hormone replacement therapy: a presentation given at the symposium to honour the retirement of Professor Martin Vessey.
Barlow DH
Pharmacoepidemiol Drug Saf; 2001; 10(1):29-32. PubMed ID: 11417063
[No Abstract] [Full Text] [Related]
13. Use of SERMs for treatment in postmenopausal women.
Pinkerton JV; Thomas S
J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
[TBL] [Abstract][Full Text] [Related]
14. [Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
Calaf Alsina J; Coronado Martín PJ
Med Clin (Barc); 2013 Mar; 140(6):266-71. PubMed ID: 23276611
[TBL] [Abstract][Full Text] [Related]
15. [Clinical experience with raloxifene].
Szúcs J; Pávó I; Jurida N
Orv Hetil; 2000 Jan; 141(5):237-40. PubMed ID: 10697982
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the breast and hormone replacement therapy for osteoporosis.
Crawshaw A
Int J Clin Pract; 2000 Mar; 54(2):99-103. PubMed ID: 10824364
[TBL] [Abstract][Full Text] [Related]
17. Is there a SERM in your menopause toolkit?
Liu JH
Menopause; 2017 Mar; 24(3):320-321. PubMed ID: 28098599
[TBL] [Abstract][Full Text] [Related]
18. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
19. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
Romero M
Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
[No Abstract] [Full Text] [Related]
20. Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing.
Jordan VC
J Natl Cancer Inst; 2001 Jan; 93(1):2-4. PubMed ID: 11136828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
